Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Oct 30;18(5):1161–1169.e5. doi: 10.1016/j.cgh.2019.10.036

Table 1.

Characteristics of patients with pancreatic cancer and controls

Discovery
set controls
(n=245)
Validation
set
controls
(n=259)
P Value All
Controls
(n=504)
PDAC
(n=245)
P Value
Age - mean (SD) 61.5 (9.5) 56.4 (10.6) <0.0001 58.9 (10.4) 67.9 (10.6) < 0.0001
Race - no. (%) 1 0.0002
White 232 (94.7) 244 (94.2) 476 (94.4) 211 (86.1)
Other 13 (5.3) 15 (5.8) 28 (5.6) 34 (13.9)
Sex - no. (%) 0.0157 0.0231
Female 121 (49.4) 156 (60.2) 277 (55.0) 113 (46.1)
Male 124 (50.6) 103 (39.9) 227 (45.0) 132 (53.9)
BMI - mean (SD) 27.4 (4.7) 27.5 (5.0) 0.5964 27.4 (4.8) 25.6 (4.1) < 0.0001
Smoker - no. (%) 0.8216 0.0507
Not current smoker 236 (96.3) 248 (95.8) 484 (96.0) 224 (91.4)
Current smoker 9 (3.7) 11 (4.2) 20 (4.0) 18 (7.3)
Diabetic~ - no. (%) 1 < 0.0001
No 228 (93.1) 240 (92.7) 36 (7.1) 90 (54.5)
Yes 17 (6.9) 19 (7.3) 468 (92.9) 75 (45.5)
Stage (8th AJCC)
I A 18 (7.3)
I B 31 (12.6)
IIA 4 (1.6)
IIB 106 (43.3)
III 86 (3.5)

Abbreviations: PDAC, pancreatic ductal adenocarcinoma; SD, standard deviation; BMI, body mass index; ~status not known for some cases